Kodiak Sciences scraps development of eye drug : comparemela

Kodiak Sciences scraps development of eye drug

Kodiak Sciences will abandon
further development of its lead drug to treat a type of eye
disease after it failed in two late-stage studies, the company
said on Monday, sending its shares tumbling more...

Related Keywords

Bengaluru , Karnataka , India , Shilpi Majumdar , Victor Perlroth , Kodiak Sciences , Reuters , Chief Executive Officer , Regeneron Pharmaceutical Eylea , California Based Kodiak , Mariam Sunny ,

© 2025 Vimarsana